J, Q., Y, X., X, L., & F, W. (2025). Clinical application of trastuzumab and docetaxel in the chemotherapy of human epidermal growth factor receptor 2 positive breast cancer patients. African journal of reproductive health, 29(5s), 97. https://doi.org/10.29063/ajrh2025/v29i5s.12
Chicago Style (17th ed.) CitationJ, Qian, Xu Y, Ling X, and Wang F. "Clinical Application of Trastuzumab and Docetaxel in the Chemotherapy of Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients." African Journal of Reproductive Health 29, no. 5s (2025): 97. https://doi.org/10.29063/ajrh2025/v29i5s.12.
MLA (9th ed.) CitationJ, Qian, et al. "Clinical Application of Trastuzumab and Docetaxel in the Chemotherapy of Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients." African Journal of Reproductive Health, vol. 29, no. 5s, 2025, p. 97, https://doi.org/10.29063/ajrh2025/v29i5s.12.